The Smartest Dividend Stocks to Buy With $10,000 Right Now

The article identifies Lancaster Colony, Colgate-Palmolive, and Clorox as attractive dividend-growth stocks for institutional investors, citing their strong financial performance and consistent dividend increases. Lancaster Colony, a specialty food producer, has shown robust revenue and net income growth, alongside a significant free cash flow turnaround, supporting 61 consecutive years of dividend hikes. Global consumer giant Colgate-Palmolive demonstrated steady sales and net income growth, substantial free cash flow, and an impressive 62-year streak of dividend increases, further bolstered by strong H1 2024 results and strategic analytics. Clorox, despite flat revenue and a cyberattack, improved gross margins and net income, consistently generating free cash flow to support its long-standing dividend growth, driven by new product development and its IGNITE strategy. All three companies exhibit strong fundamentals and clear growth strategies aimed at sustaining future dividend payouts.

Analysis

The article identifies Lancaster Colony (LANC), Colgate-Palmolive (CL), and Clorox (CLX) as compelling dividend-growth opportunities, underpinned by robust financial performance and consistent capital returns. Lancaster Colony notably reversed its free cash flow from negative $30.2 million in fiscal 2022 to a positive $184 million in fiscal 2024, alongside revenue growth from $1.68 billion to $1.87 billion over the same period. Colgate-Palmolive demonstrated steady sales growth from $17.4 billion in 2021 to $19.5 billion in 2023, supported by an average annual free cash flow of $2.5 billion.

All three companies boast exceptional dividend increase streaks, with Lancaster Colony achieving 61 consecutive years and Colgate-Palmolive an impressive 62 years. Colgate-Palmolive further reported strong H1 2024 results, including a 5.5% year-over-year revenue increase and a 21.8% rise in net income (excluding post-retirement costs). Clorox, despite flat net sales at approximately $7.1 billion from fiscal 2022 to 2024, significantly improved its gross margin from 35.8% to 43%, leading to a gross profit increase from $2.5 billion to $3 billion.

Management outlook for these firms remains optimistic, driven by strategic initiatives aimed at sustaining growth and profitability. Lancaster Colony anticipates growth from licensing programs and foodservice expansion, leveraging a new ERP system for efficiency. Colgate-Palmolive is implementing advanced analytics for SKU optimization and pricing strategies to enhance sales and margins. Clorox's IGNITE strategy, coupled with new product launches and a streamlined operating model, is expected to fuel future revenue, net income, and free cash flow growth, supporting continued dividend increases.

Key Decisions for Investors

• Investors seeking stable income and capital appreciation should consider these companies for their proven dividend growth track records and strong free cash flow generation.
• Monitor Lancaster Colony's execution on its ERP system and licensing programs for continued free cash flow improvement and top-line growth.
• Evaluate Colgate-Palmolive's advanced analytics implementation for sustained margin expansion and its ability to maintain market leadership in key categories.
• Assess Clorox's IGNITE strategy and new product pipeline for its effectiveness in driving revenue growth and further gross margin improvements, especially post-cyberattack recovery.